Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation

European Journal of Immunology

Volumn 37, Issue 8, 2007, Pages 2257-2267

  Gorbachev, Anton V ^a   Gasparian, Alexander V ^b   Gurova, Katerina V ^b   Gudkov, Andrei V ^a,b   Fairchild, Robert L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND BIOLABS INC   (United States)

Author keywords

Contact hypersensitivity; Cytokines; Dendritic cells; NF B

Indexed keywords

BAY 11 085; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MEPACRINE; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DOSE COMPARISON; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; IC 50; IN VIVO STUDY; LEUKOCYTE MIGRATION INHIBITION TEST; LYMPH NODE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION; SKIN INFLAMMATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; EPIDERMIS; FLOW CYTOMETRY; GENE EXPRESSION; INFLAMMATION; INTERLEUKIN-1BETA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NF-KAPPA B; QUINACRINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547860415     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636708     Document Type: Article

References (34)

1. Wallace D. J., The use of quinacrine (Atabrine) in rheumatic diseases: A reexamination. Semin. Arthritis Rheum. 1989. 18: 282-296.
2. Gurova, K. V., Hill, J. E., Gun, C., Prokvolit, A., Burdelya, L G., Samoylova, E., Khodyakova, A. V. et al., Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in rumors. Proc. Natl. Acad. Sd USA 2005. 102: 17448-17453.
3. Hayden, M. S. and Ghosh, S., Signaling to NF-kappaB. Genes Dev. 2004. 18: 2195-2224.
4. Bonizzi, G. and Karin, M., The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004. 25: 280-288.
5. Ghosh, S. and Karin, M., Missing pieces in the NF-kappaB puzzle. Cell 2002. 109 Suppl: S81-96.
6. Enk, A. H. and Katz, S. L., Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 1992. 89: 1398-1402.
7. Enk, A. H. and Katz, S. L., Contact sensitivity as a model for T-cell activation in skin. J. Invest. Dermatol. 1995. 105: 80S-83S.
8. Cumberbatch, M., Dearman, R. J. and Kimber, I., Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 1997 92: 388-395.
9. Eisen, H. N., Orris, L. and Balman S., Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein. J. Exp. Med. 1952. 95: 473-487
10. Kalish, R. S. and Johnson, K. L., Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J. Immunol. 1990. 145: 3706-3713.
11. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 1990. 144: 4121-4128.
12. + T cells. J. Exp. Med. 1996. 183: 1001-1012.
13. Jakob, T. and Udey, M. C., Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J. Immunol. 1998. 160: 4067-4073.
14. Saeki, H., Moore, A. M., Brown, M. J. and Hwang, S. T., Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999. 162: 2472-2475.
15. Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D. and Williams, L. T., A chemokine expressed in lymphold high endothelial venules prbomotes the adhesion and chemotaxis of naïve T lymphocytes. Proc. Natl. Acad. Sci USA 1998. 95: 258-263.
16. Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L T. and Nakano, H., Mice lacking expression of secondary lymphoid organ chemoldne have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999. 189: 451-460.
17. Jimi, E. and Ghosh, S., Role of nuclear factor-kappaB in the immune system and bone. Immunol. Rev. 2005. 208: 80-87.
18. Luo, J. L, Kamata, H. and Karin, M., IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Invest. 2005. 115: 2625-2632.
19. Carragher, D., Johal, R., Button, A., White, A., Eliopoulos, A., Jenkinson, E., Anderson, G. and Caamano, J., A stroma-derived defect in NF-kappaB2-/- mice causes impaired lymph node development and lymphocyte recruitment. J. Immunol. 2004. 173: 2271-2279.
20. + T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 2004. 172: 2286-2295.
21. + T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J. Immunol. 2001.167: 156-162.
22. + T cells independently of IL-12. J. Immunol. 2004. 173: 2443-2452.
23. Engeman, T. M., Gorbachev, A. V., Gladue, R. P., Heeger, P. S. and Fairchild, R. L., Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization. J. Immunol. 2000. 164: 5207-5214.
24. Wang, B., Fujisawa, H., Zhuang, L, Kondo, S., Shivji, G. M., Kim, C. S., Mak, T. W. and Sander, D. N., Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 1997 159: 6148-6155.
25. Wang, B., Amerio, P. and Sauder, D. N., Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol. 1999. 66: 33-39.
26. Panwalkar, A., Verstovsek, S. and Giles, F., Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies. Cancer 2004. 100: 1578-1589.
27. Wang, B., Zhuang, L., Fujisawa, H., Shinder, G. A., Feliciani, C., Shivji, G M., Suzuki, H. et al., Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 1999. 162: 277-283.
28. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., Gerritsen, M. E., Novel inhibitors of cytokine-induced IkappaBalpha-phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol Chem. 1997 272: 21096-21103.
29. Karin, M. and Lin, A., NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002. 3: 221-227
30. Kucharczak, J., Simmons, M. J., Fan, Y. and Gelinas, C., To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003. 22: 8961-8982.
31. Bruchhausen, S., Zahn, S., Valk, E., Knop, J. and Becker, D., Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers. J. Invest. Derinatol. 2003. 121: 1039-1044.
32. Al Moutaery, A. R. and Tariq, M., Effect of quinacrine, a phospholipase A2 inhibitor on stress and chemically induced gastroduodenal ulcers. Digestion 1997. 58: 129-137.
33. Czerniecki B., Witz, G., Reilly, C. and Gad, S. C., The development of contact hypersensitivity in mouse skin is suppressed by tumor promoters. J. Appl. Taxicol 1988. 8: 1-8.
34. + T cells. J. Immunol. 1997.158: 4721-4728.